The role of eosinophils in ocular allergy

International Ophthalmology Clinics

Volumn 43, Issue 1, 2003, Pages 9-25

  Srivastava, Ajay ^a   Sur, Sanjiv ^b   Trocmé, Stefan D ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; COMPLEMENT RECEPTOR; CYTOKINE; EOSINOPHIL CATIONIC PROTEIN; EOSINOPHIL PEROXIDASE; EOSINOPHIL PROTEIN X; IMMUNOGLOBULIN RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 5; LEUKOTRIENE RECEPTOR; MAJOR BASIC PROTEIN; MEMBRANE PROTEIN; MEMBRANE RECEPTOR; THROMBOCYTE ACTIVATING FACTOR RECEPTOR;

ALLERGIC DISEASE; APOPTOSIS; ARTICLE; CHEMOTAXIS; CONJUNCTIVITIS; EOSINOPHIL; HAY FEVER; KERATOCONJUNCTIVITIS; PRIORITY JOURNAL; VERNAL CONJUNCTIVITIS;

EID: 0037412723     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004397-200343010-00004     Document Type: Article

References (86)

1. Gleich GJ, Adolphson CR. The eosinophilic leukocyte: structure and function. Adv Immunol 1986;39:177-253
2. Opie EL. An experimental study of the relation of cells with eosinophil granulation to infection with an animal parasite, Trichina spiralis 1904;127:477-493
3. Schlecht H, Schwenker G. Über die beziehungen der eosinophilie zur anaphylaxie. Dtsch Arch Klin Med 1912;108:405-428
4. Triggiani M, Calabrese C, Granata F, et al. Metabolism of lipid mediators in human eosinophils. Chem Immunol 2000;76:77-98
5. Costa JJ, Weller PF, Galli SJ. The cells of the allergic response: mast cells, basophils, and eosinophils. JAMA 1997;278:1815-1822
6. Kita H, Adolphson CR, Gleich GJ. Biology of eosinophils. In: Middleton E Jr, Reed CE, Ellis EF, et al, eds. Allergy: principles and practice, ed 5. St Louis: Mosby, 1998:242-260
7. Sur S, Adolphson CR, Gleich GJ. Eosinophils: biochemical and cellular aspects. In: Middleton E Jr, Reed CE, Ellis EF, et al. eds. Allergy: principles and practice, ed 4. St Louis: Mosby, 1993:169-200
8. Gleich GJ. Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 2000;105:651-663
9. Rothenberg ME. Mechanisms of diseases: eosinophilia [review articles]. N Engl J Med 1998;338:1592-1600
10. Sehmi R, Denburg JA. Differentiation of human eosinophils. Role in allergic inflammation. Chem Immunol 2000;76:29-44
11. Bochner BS, Schleimer RP. Mast cells, basophils, and eosinophils: distinct but overlapping pathways for recruitment. Immunol Rev 2001;179:5-15
12. Dvorak AM: Similarities in the ultrastructural morphology and developmental and secretory mechanisms of human basophils and eosinophils. J Allergy Clin Immunol 1994;94:1103-1134
13. Trocme SD, Aldave AJ. The eye and the eosinophil. Surv Ophthalmol 1994;39:241-252
14. Dvorak AM, Ackerman SJ, Weller PF. Subcellular morphology and biochemistry of eosinophils. In: Smolin GS, O'Connor GR, eds. Ocular immunology, ed 2. Boston: Little, Brown, and Co, 1986:237-344
15. Dvorak AM, Weller PF. Ultrastructural analysis of human eosinophils. Chem Immunol 2000;76:1-28
16. Tachimoto H, Bochner BS. The surface phenotype of human eosinophils. Chem Immunol 2000;76:45-62
17. Dombrowicz D, Woerly G, Capron M. IgE receptors on human eosinophils. Chem Immunol 2000;76:63-76
18. Daffern PJ, Pfeifer PH, Ember JA, et al. C3a is a chemotaxin for human eosinophils but not for neutrophils: I. C3a stimulation of neutrophils is secondary to eosinophil activation. J Exp Med 1995;181:2119-2127
19. Stellato C, Beck LA. Expression of eosinophil-specific chemokines by human epithelial cells. Chem Immunol 2000;76:156-176
20. Kitaura M, Nakajima T, Imai T, et al. Molecular cloning of human eotaxin, an eosinophil-selective CC chemokine, and identification of a specific eosinophil eotaxin receptor, CC chemokine receptor 3. J Biol Chem 1996;271:7725-7730
21. Wells TN, Power CA, Lusti-Narasimhan M, et al. Selectivity and antagonism of chemokine receptors. J Leukoc Biol 1996;59:53-60
22. Murphy PM. Chemokine receptors: structure, function and role in microbial pathogenesis. Cytokine Growth Factor Rev 1996;7:47-64
23. Assa'ad AH, Spicer RL, Nelson DP, et al. Hypereosinophilic syndromes. Chem Immunol 2000;76:208-229
24. Spada CS, Woodward DF, Hawley SB, et al. Leukotrienes cause eosinophil emigration into conjunctival tissue. Prostaglandins 1986;31:795-809
25. Spada CS, Nieves AL, Krauss AH, et al. Comparison of leukotriene B4 and D4 effects on human eosinophil and neutrophil motility in vitro. J Leukoc Biol 1994;55:183-191
26. Ackerman SJ, Loegering DA, Venge P, et al. Distinctive cationic proteins of the human eosinophil granule: major basic protein, eosinophil cationic protein and eosinophil-derived neurotoxin. J Immunol 1983;131:2977-2982
27. Gleich GJ, Loegering DA, Maldonado JE. Identification of a major basic protein in guinea pig eosinophil granules. J Exp Med 1973;137:1459-1471
28. Gleich GJ, Loegering DA, Kueppers F, et al. Physiochemical and biological properties of the major basic protein from guinea pig eosinophil granules. J Exp Med 1974;140:313-332
29. Gleich GJ, Adolphson CR, Leiferman KM. The biology of the eosinophilic leukocyte. Ann Rev Med 1993;44:85-101
30. Abu-Ghazaleh RI, Gleich GJ, Prendergast FG. Interaction of eosinophil granule major basic protein with synthetic lipid bilayers: a mechanism for toxicity. J Membr Biol 1992;128:153-164
31. Carlson MG, Peterson CG, Venge P. Human eosinophil peroxidase: purification and characterization. J Immunol 1985;134:1875-1879
32. Ben G, Bolscher JM, Plat H, et al. Some properties of human eosinophil peroxidase: a comparison with other peroxidases. Biochim Biophys Acta 1984;784:177-186
33. Egesten A, Alumets J, von Mecklenburg C, et al. Localization of the eosinophil cationic protein, major basic protein and eosinophil peroxidase in human eosinophils by immunoelectron microscopic technique. J Histochem Cytochem 1986;34:1399-1403
34. Arlandson M, Decker T, Roongta VA, et al. Eosinophil peroxidase oxidation of thiocyanate. Characterization of major reaction products and a potential sulfhydryl-targeted cytotoxicity system. J Biol Chem 2001;276:215-224
35. O'Brien PJ. Peroxidases. Chem Biol Interact 2000;129:113-139
36. Hamann KJ, Barker RL, Checkel JL, et al. Eosinophil peroxidase-mediated toxicity to microfilariae of Brugia pahangi and Brugia malayi. Fed Proc 1987;46:615
37. Nakajima H, Loegering DA, Gleich GJ. Cytotoxicity of eosinophil granule proteins for tumor cells [abstract 2994]. FASEB J 1988;2:A811
38. Jong EC, Mahmoud AA, Klebanoff SJ. Peroxidase-mediated toxicity to schistosomula of Schistosoma mansoni. J Immunol 1981;126:468-471
39. Jong EC, Henderson AR, Kelebanoff SJ. Bactericidal activity of eosinophil peroxidase. J Immunol 1980;124:1378-1382
40. Jong EC, Klebanoff SJ. Eosinophil-mediated mammalian tumor cell cytotoxicity: role of the peroxidase system. J Immunol 1980;124:1949-1953
41. Leonardi A, Borghesan F, Faggian D, et al. Eosinophil cationic protein in tears of normal subjects and patients affected by vernal keratoconjunctivitis. Allergy 1995;50:610-613
42. Peters MS, Rodriguez M, Gleich GJ. Localization of human eosinophil granule major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin by immunoelectron microscopy. Lab Invest 1986;54:656-662
43. Ding-E Young J, Peterson CG, Venge P, et al. Mechanism of membrane damage mediated by human eosinophil cationic protein. Nature 1986;321:613-616
44. Ackerman SJ, Gleich GJ, Loegering DA, et al. Comparative toxicity of purified human eosinophil granule cationic proteins for schistosomula of Schistosoma mansoni. Am J Trop Med Hyg 1985;34:735-745
45. Rosenberg HF, Ackerman SJ, Tenen DG. Human eosinophil cationic protein. Molecular cloning of a cytotoxin and helminthotoxin with ribonuclease activity. J Exp Med 1989;170:163-176
46. Fredens K, Dahl R, Venge P. In vitro studies of the interaction between heparin and eosinophil cationic protein. Allergy 1991;46:27-29
47. Hernnas J, Sarnstrand B, Lindroth P, et al. Eosinophil cationic protein alters proteoglycan metabolism in human lung fibroblast cultures. Eur J Cell Biol 1992;59:352-363
48. Gleich GJ, Loegering DA, Bell MP, et al. Biochemical and functional similarities between eosinophil-derived neurotoxin and eosinophil cationic protein: homology with ribonuclease. Proc Natl Acad Sci USA 1986;83:3146-3150
49. Ackerman SJ, Liu L, Kwatia MA, et al. Charcot-Leyden crystal (CLC) protein (galectin-10) is not a dual function galectin with lysophospholipase activity but binds a lysophospholipase inhibitor in a novel structural fashion. J Biol Chem 2002;277:14859-14868
50. Swaminathan GJ, Leonidas DD, Savage MP, et al. Selective recognition of mannose by the human eosinophil Charcot-Leyden crystal protein (galectin-10): a crystallographic study at 1.8 A resolution. [Erratum appears in Biochemistry 1999 Nov 16;38(46): 15406.] Biochemistry 1999;38:13837-13843
51. Lacy P, Moqbel R. Eosinophil cytokines. Chem Immunol 2000;76:134-155
52. Walsh GM. Human eosinophils: their accumulation, activation and fate. Br J Haematol 1997;97:701-709
53. Horie S, Gleich GJ, Kita H. Cytokines directly induce degranulation and superoxide production from human eosinophils. J Allergy Clin Immunol 1996;98:371-381
54. Weller PF, Rand TH, Barrett T, et al. Accessory cell function of human eosinophils. HLA-DR-dependent, MHC-restricted antigen-presentation and IL-1 alpha expression. J Immunol 1993;150:2554-2562
55. Lipowsky HH, Scott DA, Cartmell JS. Leukocyte rolling velocity and its relation to leukocyte-endothelium adhesion and cell deformability. Am J Physiol 1996;270:H1371-1380
56. Burke-Gaffney A, Blease K, Hartnell A, et al. TNF-alpha potentiates C5a-stimulated eosinophil adhesion to human bronchial epithelial cells: a role for alpha 5 beta 1 integrin. J Immunol 2002;168:1380-1388
57. Walsh GM. Eosinophil apoptosis: mechanisms and clinical relevance in asthmatic and allergic inflammation. Br J Haematol 2000;111:61-67
58. Simon HU. Regulation of eosinophil and neutrophil apoptosis - similarities and differences. Immunol Rev 2001;179:156-162
59. Simon HU, Alam R. Regulation of eosinophil apoptosis: transduction of survival and death signals. Int Arch Allergy Immunol 1999;118:7-14
60. Brown SB, Savill J. Phagocytosis triggers macrophage release of Fas ligand and induces apoptosis of bystander leukocytes. J Immunol 1999;162:480-485
61. Fecho K, Cohen PL. Fas ligand (gld)- and Fas (lpr)-deficient mice do not show alterations in the extravasation or apoptosis of inflammatory neutrophils. J Leukoc Biol 1998;64:373-383
62. Dibbert B, Daigle I, Braun D, et al. Role for Bcl-xL in delayed eosinophil apoptosis mediated by granulocyte-macrophage colony-stimulating factor and interleukin-5. Blood 1998;92:778-783
63. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998;281:1309-1312
64. Fukagawa K, Nakajima T, Saito H, et al. IL-4 induces eotaxin production in corneal keratocytes but not in epithelial cells. Int Arch Allergy Immunol 2000;121:144-150
65. Trocme SD, Raizman MB, Bartley GB. Medical therapy for ocular allergy. Mayo Clin Proc 1992;67:557-565
66. Bacon AS, McGill JI, Anderson DF, et al. Adhesion molecules and relationship to leukocyte levels in allergic eye disease. Invest Ophthalmol Vis Sci 1998;39:322-330
67. Foster CS. The pathophysiology of ocular allergy: current thinking. Allergy 1995;50:6-9; discussion, 34-38
68. Smolin G, O'Connor GR. Ocular immunology, ed 2. Boston: Little, Brown and Co, 1986
69. Abelson MB, Madiwale N, Weston JH. Conjunctival eosinophils in allergic ocular disease. Arch Ophthalmol 1983;101:555-556
70. Friedlaender MH, Okumoto M, Kelly J. Diagnosis of allergic conjunctivitis. Arch Ophthalmol 1984;102:1198-1199
71. Montan PG, Van Hage-Hamsten M. Eosinophil cationic protein in tears in allergic conjunctivitis. Br J Ophthalmol 1996;80:556-560
72. Montan PG, Van Hage-Hamsten M, Zetterstrom O. Sustained eosinophil cationic protein release into tears after a single high-dose conjunctival allergen challenge. Clin Exp Allergy 1996;26:1125-1130
73. Buckley RJ. Vernal keratoconjunctivitis. Int Ophthalmol Clin 1988;28:303-308
74. Tomassini M, Magrini L, Bonini S, et al. Increased serum levels of eosinophil cationic protein and eosinophil-derived neurotoxin (protein X) in vernal keratoconjunctivitis. Ophthalmology 1994;101:1808-1811
75. Friedlaender MH. Corneal findings in ocular allergy. Int Ophthalmol Clin 1998;38:39-46
76. Udell IJ, Gleich GJ, Allansmith MR, et al. Eosinophil granule major basic protein and Charcot-Leyden crystal protein in human tears. Am J Ophthalmol 1981;92:824-828
77. Trocme SD, Kephart GM, Allansmith MR, et al. Conjunctival deposition of eosinophil granule major basic protein in vernal keratoconjunctivitis and contact lens-associated giant papillary conjunctivitis. Am J Ophthalmol 1989;108:57-63
78. Trocme SD, Kephart GM, Bourne WM, et al. Eosinophil granule major basic protein deposition in corneal ulcers associated with vernal keratoconjunctivitis. Am J Ophthalmol 1993;115:640-643
79. Trocme SD, Gleich GJ, Kephart GM, et al. Eosinophil granule major basic protein inhibition of corneal epithelial wound healing. Invest Ophthalmol Vis Sci 1994;35:3051-3056
80. Abu El-Asrar AM. Gelatinase B in vernal keratoconjunctivitis. Arch Ophthalmol 2001;119:1505-1511
81. Hogan MJ. Atopic keratoconjunctivitis. Am J Ophthalmol 1953;36:937-947
82. Friedlaender MH. Current concepts in ocular allergy. Ann Allergy 1991;67:5-10
83. Trocme SD, Hallberg CK, Gill KS, et al. Effects of eosinophil granule proteins on human corneal epithelial cell viability and morphology. Invest Ophthalmol Vis Sci 1997;38:593-599
84. Fukagawa K, Nakajima T, Tsubota K, et al. Presence of eotaxin in tears of patients with atopic keratoconjunctivitis with severe corneal damage. J Allergy Clin Immunol 1999;103:1220-1221
85. Bacon AS, Tuft SJ, Metz DM, et al. The origin of keratopathy in chronic allergic eye disease: a histopathological study. Eye 1993;7:21-25
86. Hingorani M, Calder V, Jolly G, et al. Eosinophil surface antigen expression and cytokine production vary in different ocular allergic diseases. J Allergy Clin Immunol 1998;102:821-830